HAS2-Ezrin-ER axis plays a role in acquired antiestrogen resistance of ER-positive breast cancerXiaodan Sun, Cuixia Yang|Frontiers in Pharmacology|2022Cited by 6
Loss of HAS2 Confers Acquired Antiestrogen Resistance By Upregulating Ezrin Expression In ER-Positive Breast CancerXiaodan Sun, Cuixia Yang, Yiwen Liu et al.|Research Square|2022Cited by 1